BioSpace News Archive

Menarini Silicon Biosystems (MSB), a pioneer of single cell technologies, announced today its new FFPE Rescue Application, to enable molecular testing on formalin-fixed, paraffin-embedded (FFPE) samples with low tumor cell contents.

Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association’s 2021 Workplace Health Achievement Index, ranking the company’s workplace health initiative among the best in the nation.

Nova Mentis Life Science Corp and Mycrodose Therapeutics announce the successful milestone of merging NOVA’s psilocybin-based drug development program with Mycrodose’s transdermal technology.

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced a collaboration with Pfizer Global Medical Grants (Pfizer) that awards new grants to advance the understanding of the mechanisms of action, underlying biology, and clinical activity of talazoparib in prostate cancer.

Apnimed today announced the dosing of the first patient in the Phase 2b MARIPOSA study of AD109, the company’s lead investigational oral medication for the treatment of OSA.

Haematologic Technologies today announced the appointment of John Strokis as Vice President, Quality.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the launch of NeXT Personal, a next-generation, tumor-informed liquid biopsy assay designed to detect and quantify molecular residual disease (MRD) and recurrence in patients previously diagnosed with cancer.

Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced it has dosed the first patients in its ILD-DLCO Trial.

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the successful completion of its acquisition of Soliton, Inc. (NASDAQ: SOLY).

Medtronic plc, a global leader in healthcare technology, made two announcements regarding its executive committee.